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Background: B cell receptor (BCR) clusters modulate BCR signaling in B-lymphocytes.
Results:We used a quantitative proteomic proximity assay to analyze the BCR cluster in DT40 cells.
Conclusion:Our proximity labeling assay identified novel components of the BCR cluster linked to integrin signaling.
Significance: We provide new insights into BCR assembly and identify new and unexpected targets for further functional
analysis.
In the vertebrate immune system, each B-lymphocyte
expresses a surface IgM-class B cell receptor (BCR). When
cross-linked by antigen or anti-IgM antibody, the BCR accumu-
lates with other proteins into distinct surface clusters that acti-
vate cell signaling, division, or apoptosis. However, the molecu-
lar composition of these clusters is not well defined. Here we
describe a quantitative assay we call selective proteomic prox-
imity labeling using tyramide (SPPLAT). It allows proteins in
the immediate vicinity of a target to be selectively biotinylated,
and hence isolated for mass spectrometry analysis. Using the
chicken B cell line DT40 as a model, we use SPPLAT to provide
the first proteomic analysis of any BCR cluster using proximity
labeling. We detect known components of the BCR cluster,
including integrins, together with proteins not previously
thought to be BCR-associated. In particular, we identify the
chicken B-lymphocyte allotypic marker chB6. We show that
chB6 moves to within about 30–40 nm of the BCR following
BCR cross-linking, and we show that cross-linking chB6 acti-
vates cell binding to integrin substrates laminin and gelatin.Our
work provides new insights into the nature and composition of
the BCR cluster, and confirms SPPLAT as a useful research tool
in molecular and cellular proteomics.
The B cell receptor (BCR)6 is an IgM class immunoglobulin
present on the plasma membrane of B-lymphocytes. When
either soluble or membrane-bound antigen binds to the BCR it
becomes cross-linked, and assembles into spatially restricted
and functionally integrated protein clusters (1). The cross-
linked BCRs enter lipid rafts, and drive their coalescence (2).
These events activate a complex series of signal transduction
pathways, followed by the “capping” and endocytosis of the
BCR-antigen complex (3). As a consequence, the B-lympho-
cyte can either undergo division and differentiation, ulti-
mately to produce an antibody-secreting plasma cell, or can
initiate apoptosis. Which pathway is followed depends on
the developmental stage of the B-lymphocyte and its immu-
nological context (4).
The molecular composition of the BCR cluster is of consid-
erable interest. Currently, however, it is not well characterized,
and the proteomic analysis of such clusters represents a signif-
icant technical challenge (5). This is in part because the BCR
clusters are highly dynamic, and their compositionmay change
during the BCR cross-linking process (1, 6). More fundamen-
tally, proteins that become concentrated in these clusters may
not necessarily bind each other directly, or may bind only
weakly. Traditional isolation methods such as immunoprecipi-
tation may not be effective in this case. Although cross-linking
could theoretically be used, in practice it can be difficult to
control (7).
We believe that alternative analytical methods will be
required to better survey protein diversity within membrane-
localized structures such as the BCR cluster. Recently, several
groups have described the use of “proximity labeling assays” for
the investigation of membrane proteins (8, 9). In these meth-
ods, an appropriately targeted peroxidase enzyme acts on a sub-
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strate to generate a short-lived product capable of covalently
labeling proteins in the immediate vicinity of the enzyme. The
labeled proteins can then be isolated by standard affinity chro-
matography, and identified by mass spectrometry (MS).
Here we describe a new variation of proximity labeling,
which combines cleavable tyramide-biotin chemistry with high
throughput proteomics, made quantitative using stable isotope
labeling by amino acids in cell culture (SILAC). We use the
method to provide the first proteomic analysis of a cross-linked
BCR cluster on any B-lymphocyte. For our model, we use the
avian leukosis virus-transformed chicken cell line DT40 (10).
This cell line is derived from an immature B-lymphocyte (11).
TheDT40 cell line is widely used for functional studies, because
its high rate of homologous recombination greatly facilitates
gene targeting (10). The genes for several proteins within the
BCR signaling pathway have been knocked out inDT40 and the
functional consequences investigated (12). DT40 cells can also
be grown in large numbers, aiding proteomic analysis (13).
DT40 cells therefore represent an attractive and physiologically
relevantmodel systemonwhich to apply our proximity labeling
assay.
We identify known and suspected components of the BCR
clusters, including the lipid raft marker raftlin (14) and integ-
rins (15). We also detect proteins not previously linked to BCR
cluster assembly. Surprisingly, we detect protein chB6, a mole-
cule long used as an important allotypic marker for avian
B-lymphocyte development, but whose function is currently
unknown (16). We show that chB6 is partitioned between lipid
rafts and non-raft regions of the DT40 plasma membrane, and
we show that BCR clustering drives the close association of chB6
with the BCR. Analysis of the chB6 primary sequence suggests
structural similarities to immunoglobulin (Ig) domain-containing
signaling and cell-adhesion molecules. Consistent with this view,
we show that chB6 cross-linking activates integrin-mediated cell
binding. Our results confirm the potential of proximity labeling
assays for the analysis of the BCR cluster, and identify new targets
for further functional studies.
EXPERIMENTAL PROCEDURES
Buffers—The composition of buffers used in the biotinyla-
tion, purification, and immunofluorescence experiments were
as follows: tyramide labeling buffer (50 mM Tris-HCl, pH 7.4,
with fresh 0.03% H2O2 containing 80 g/ml of tyramide-biotin
label), antibody strip buffer (50 mM glycine, pH 3.0, 150 mM
NaCl, 0.9 mM CaCl2, 0.5 mM MgCl2), cell lysis buffer (20 mM
Tris-HCl, pH 7.5, 5 mM EDTA, 1 protease inhibitor mixture
(Roche Applied Science), 150 mMNaCl, 1% (v/v) Triton X-100,
0.1 M sodium thiocyanate), wash buffer 1 (10 mM Tris, pH 7.4,
1% (v/v) Triton X-100, 1 mM EDTA, 0.5% (w/v) SDS, 500 mM
NaCl, 1 protease inhibitor mixture, 0.1 mg/ml of PMSF
(Sigma), 0.1M sodium thiocyanate), wash buffer 2 (0.1M sodium
thiocyanate, 10 mM Tris, pH 7.4, 1% (v/v) Triton X-100, 1 mM
EDTA, 0.5% (w/v) SDS, 1 protease inhibitor, 0.1 mg/ml of
PMSF), elution buffer (0.1 M sodium thiocyanate, 1% (w/v) SDS,
5mMTCEP (Thermo), 100mMTris, pH 7.4, 1 protease inhib-
itor mixture, 0.1 mg/ml of PMSF), immunofluorescence wash
buffer (PBS containing 0.5% saponin, 0.1% Triton X-100),
immunofluorescence blocking buffer (immunofluorescence
wash buffer containing 10% non-immune goat serum), immu-
nofluorescence reducing buffer (5mMTCEP in 150mMNaCl, 1
mMEDTA, 0.2%BSA, 20mMTris, pH8.6) (17), andTBS-Tween
(25 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.5).
Tyramide-biotin Label Preparation—The cleavable tyra-
mide-biotin label was prepared by gently mixing 5 mg of EZ-
LinkNHS-SS-biotin (Thermo)with 1.55mgof tyramine hydro-
chloride (Sigma) in 2 ml of 50 mM borate, pH 8.8, overnight, at
room temperature in the dark (18). After filteringwith a 0.2-m
filter the label was stored at20 °C.
Cell Culture—Routine growth andmaintenance of the DT40
cell line was as previously described (13). For SILAC experi-
ments, RPMI 1640 heavy medium contained 13C6-labeled L-ly-
sine and L-arginine (K6R6), whereas the light medium was
RPMI 1640 containing non-labeled L-lysine and L-arginine
(K0R0), both of which were supplemented with 10% dialyzed
fetal bovine serum (all fromDundeeCell Products), 1%dialyzed
chicken serum (in house), 2 mM L-glutamine, 100 units/ml of
penicillin, and 100g/ml of streptomycin (all from Invitrogen).
Tyramide-biotin Labeling—Exponentially growing cells were
pelleted and washed in phosphate-buffered saline (PBS) at
room temperature. About 5  108 cells were incubated with
end over end rotation for 2 h with 20g/ml of HRP-conjugated
goat anti-chicken IgM (Bethyl Ltd.), or 20 g/ml of HRP-con-
jugated goat anti-rabbit IgG (Bio-Rad) in 20ml of PBSwith 10%
(v/v) goat serum (Ultraclone Ltd.) at 4 °C. Cells were pelleted
and re-suspended in 10 ml of tyramide-labeling buffer and
incubatedwith end over end rotation at room temperature for 5
min. After incubation, 100 units/ml of catalase (Sigma) was
added and incubated with the samples for a further 5 min to
quench H2O2. Cells were washed gently with 45 ml of antibody
strip buffer and left on ice for 5min. Cells were re-suspended in
1 ml of cell lysis buffer and incubated for 30 min on ice. Insol-
uble material was removed by centrifugation for 4 min at
130,000 g and protein-containing soluble fraction was recov-
ered for streptavidin-bead capture.
Affinity Purification of Biotinylated Proteins—The same
amount of specifically and nonspecifically biotinylated proteins
(1.04 mg (1st SILAC) and 0.78 mg (2nd SILAC)) were mixed
and incubated with 0.25 ml of streptavidin-agarose beads in 1
ml of cell lysis buffer. The beads were washed twice with 1ml of
ice-cold wash buffer containing sodium thiocyanate to reduce
nonspecific interactions (19). Beads were then incubated in 1
ml of elution buffer with rotation for 1 h at 4 °C. The biotiny-
lated proteins were recovered by centrifugation and concen-
trated by vacuum drying. Proteins were separated by SDS-
PAGE (10%). The gels were stained with colloidal Coomassie
Blue prior to dividing and excising into four equal strips. Gel
slices were destained in ddH2O and 20mMNH4HCO3, reduced
with 2mMDTT, and alkylated with 10mM iodoacetamide prior
to overnight digestion with 2 g of sequencing grade trypsin
(Promega). Peptides were extracted with acetonitrile and 1%
formic acid and re-suspended inwaterwith 1% formic acid after
vacuum drying.
Immunoaffinity Purification of the BCR—5  108 cells were
separately incubated with either HRP-conjugated goat anti-
chicken IgM or HRP-conjugated goat anti-rabbit IgG control,
lysed as described above. About 1.7mg of cell lysate proteinwas
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incubated with 0.25 ml of bead slurry of rabbit anti-goat IgG-
Sepharose (Sigma) overnight at 4 °C, washed extensively with
cold PBS, and protein was eluted with 1 ml of 0.1 M glycine, pH
2.5, at 4 °C. Samples were concentrated by freeze drying and
separated by SDS-PAGE (4–12% gradient gels). Four equal
sized bands were excised and processed for trypsin digestion as
above.
Liquid Chromatography-Mass Spectrometry—All LC-MS/MS
SPPLAT experiments were performed using a nanoAcquity
UPLC system (Waters Corp., Milford, MA) and an LTQ
Orbitrap Velos hybrid ion trap mass spectrometer (Thermo
Scientific, Waltham, MA). Separation of peptides was per-
formed by reverse-phase chromatography using a Waters
reverse-phase nanocolumn (BEHC18, 75m inner diameter
250 mm, 1.7-m particle size) at a flow rate of 300 nl/min.
Peptides were initially loaded onto a pre-column (Waters
UPLC Trap Symmetry C18, 180 m inner diameter 20 mm,
5-mparticle size) from the nanoAcquity samplemanagerwith
0.1% formic acid for 3min at a flow rate of 10l/min. After this
period, the column valve was switched to allow the elution of
peptides from the pre-column onto the analytical column
where a linear gradient of increasing acetonitrile (5–35%) over
60minwas employed. The LC eluant was sprayed into themass
spectrometer bymeans of a nanospray source. Allm/z values of
eluting ions were measured in the Orbitrap Velos mass ana-
lyzer, set at a resolution of 30,000. Data-dependent scans (top
10) were employed to automatically isolate and generate frag-
ment ions by collision-induced dissociation in the linear ion
trap, resulting in the generation of MS/MS spectra. Ions with
charge states of 2 and above were selected for fragmentation.
Post-run, the data were processed using Protein Discoverer
(version 1.2, Thermo Scientific).
SILACDataAnalysis—The rawMSdata files were converted
to mgf files and searched against the UniprotKB Gallus gallus
database (2012, 27,000 entries) using the Mascot search algo-
rithm (version 2.2.07,Matrix Science, London,UK)withmethi-
onine oxidation (M) as a variable modification and cysteine
carbamidomethylation (C) as a fixed modification, allowing 2
missed cleavages, a peptide mass tolerance of 1 Da, and a
fragmentmass tolerance of 0.8Da.Quantitationwas performed
using MaxQuant (version 1.0.3.5). Raw data were searched
usingAndromeda (20), withArg-6 andLys-6 set as heavy labels,
methionine oxidation and N-acetylation as variable modifica-
tions, and cysteine carbamidomethylation as a fixed modifica-
tion. The proteins were considered to be identified if there was
at least one unique peptide and to be quantified if there were at
least two unique peptides. Only unique peptides were used for
quantitation.
BCR Immunoprecipitation—LC-MS/MS experiments were
performed as above but using a nanoLC Ultra 1D plus system
(Eksigent Corp., Dublin, CA) and an LTQOrbitrap at a resolu-
tion of 60,000. Peptides were initially loaded onto an in-house
pre-column (100m inner diameter 40mm, 3.6-mparticle
size) from a nanoLCAS-2 autosampler with 0.5% formic acid at
a flow rate of 1.5 l/min, then further separated using an in-
house reverse-phase nanocolumn (Phenomenex, kinetex C18,
75minner diameter 150mm, 2.6-mparticle size) at a flow
rate of 250 nl/min for 120min. Peptidemass tolerance was20
ppm and fragment mass tolerance was 0.8 Da. Significance
threshold was set to p 0.05 and ion score cut off was set to 0.
Protein abundance was estimated by calculating emPAI scores
(21).
Immunoprecipitation of Selected Biotinylated Proteins—
Tyramide-biotin labeling of about 5 108 cells was carried out
as described above. Cells were lysed in 0.5 ml of lysis buffer
without sodium thiocyanate for 30min at 4 °C. Insoluble mate-
rial was removed by brief centrifugation (2000  g, 3 min).
Lysate supernatants were separately incubated with mouse
monoclonal anti-CDC42 (Abcam ab170048) (1:100 dilution) or
mouse FU5–11G2 monoclonal anti-chB6 (1:100 ascites (22))
overnight at 4 °C. Samples were then incubated with 0.05 ml of
slurry of protein G-Sepharose (Sigma) with end over end rota-
tion for 2 h at 4 °C and pelleted by centrifugation (2000  g, 3
min). To remove weakly interacting proteins, pellets were
washed four times in 1.5 ml of ice-cold lysis buffer and four
times in 1.5ml of ice-cold lysis buffer containing 0.75MNaCl all
without sodium thiocyanate, with 5-min incubations between
spins. The immunoprecipitated proteins were then eluted with
0.08ml of antibody strip buffer at 50 °C for 5min. The resulting
supernatants were separated by SDS-PAGE (10%) without
reducing agent and electrophoretically transferred onto a
PVDF membrane using the iBlot gel transfer system (Invitro-
gen). Separate blotted samples were blocked for 3 h at 4 °C with
4% BSA in TBS-Tween, then probed overnight at 4 °C with
affinity-purified rabbit anti-chB6 specific peptide EMIAD-
VESQENASNC (Dragonfly Sciences, Wellesley, MA) (1:200
dilution in TBS-Tween), or polyclonal rabbit anti-CDC42
(Abcam ab175270) (1:100 dilution inTBS-Tween).Membranes
were washed with TBS-Tween, then probed with HRP-conju-
gated goat anti-rabbit (Dako) at 1:5000 dilution in TBS-Tween
for 1 h at room temperature. Themembraneswere thenwashed
with TBS-Tween four times for 5 min each at room tempera-
ture. Bands were visualized by enhanced chemiluminescence
(Pierce). In parallel, separate blots were incubated with HRP-
conjugated streptavidin (Molecular Probes) (1:8000 dilution in
TBS-Tween) for 1 h at 4 °C to detect biotinylation. Blots were
washed as above, and bands were visualized by enhanced
chemiluminescence (Pierce).
Co-localization of BCR and Deposited Tyramide-biotin—DT40
cells were incubated with HRP-conjugated goat anti-chicken
IgM, or HRP-conjugated goat anti-rabbit IgG and tyramide
biotinylated as described above. Cells were attached to cover-
slips pre-coated with 0.05% poly-L-lysine and fixed with 4%
paraformaldehyde in PBS for 10 min at room temperature as
described previously (13). Cells were washed four times in
immunofluorescence wash buffer followed by immunofluores-
cence blocking buffer for 1 h at room temperature. Cells were
stained with FITC-conjugated donkey anti-goat IgG (1:100)
and Alexa 568-conjugated avidin (1:2000) (both Abcam) in
blocking buffer for 1 h at room temperature. Cells were washed
four times, and coverslips were mounted with Vectashield
(Vector) and examined using an Olympus Fluoview IX81 laser
scanning confocalmicroscope. To test for surface biotinylation,
cells were preincubated with HRP-conjugated anti-chicken
IgM, tyramide-biotinylated as described above, then half the
cell population was incubated with immunofluorescence
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reducing buffer for 10 min. Cells were stained with FITC-con-
jugated anti-goat IgG to detect BCR and Texas Red-conjugated
avidin to detect the remaining biotin. Images were rendered in
pseudo-three-dimensional using ImageJ software (National
Institutes of Health; rsbweb.nih.gov/ij).
Immunofluorescence—For integrin and BCR immunofluo-
rescence, cells were preincubated with HRP-conjugated anti-
chicken IgM, fixed, permeabilized, and incubated with FITC-
conjugated donkey anti-goat IgG as above for 1 h. Cells were
washed six times in immunofluorescence wash buffer. Cells
were incubated with mouse anti-chicken 1 integrin subunit
(1:100) (Developmental Studies Hybridoma Bank) for 1 h in
immunofluorescence wash buffer. Cells were washed six times
with immunofluorescence blocking buffer, followed by staining
with Alexa 568-conjugated anti-mouse IgG (1:100) (Sigma) in
immunofluorescence blocking buffer. Cells were processed and
analyzed for fluorescence microscopy as above. Control cells
lacking either HRP-conjugated anti-IgM or primary antibodies
were identically processed.
For co-localization of chB6 and lipid rafts, 106 cells were
suspended with primary antibody FU5-11G2 (mouse anti-
chB6.2 ascites (22)), diluted 1:100, and incubated for 20 min on
ice. The cells were then washed twice and resuspended with
FITC-conjugated anti-mouse IgG secondary antibody, diluted
1:200 (Millipore, Temecula, CA), and Alexa 568-conjugated
cholera toxin subunit B (Invitrogen) diluted 1:800. The cells
were then incubated for 20 min on ice. The cells were washed
twice and then resuspended in PBS. Images of chB6 immuno-
fluorescence and lipid raft overlay were acquired on an epifluo-
rescence microscope (Nikon Eclipse E600) with40 objective.
Images were processed with SPOT Advanced software (Diag-
nostic Instruments, Inc., Sterling Heights, MI).
Lipid Raft Isolation and Western Blot Analysis of Membrane
Fractions—Detergent-soluble and -insoluble membrane frac-
tions were prepared according to the method of Xie et al. (23).
Briefly, 2 107 DT40 cells were washed and the cell pellet was
resolubilized in 1% Brij 58 lysis buffer (1% Brij 58, 20 mM Tris,
pH 7.5, 150 mM NaCl, with protease and phosphatase inhibi-
tors). Lysis was allowed to proceed for 30 min on ice. The cell
lysate was then centrifuged at 14,000  g for 25 min at 4 °C to
separate Brij-soluble and -insoluble fractions. The supernatant
(Brij detergent-soluble or non-lipid raft fraction) was kept on
ice until later use. The detergent-insoluble pellet (lipid rafts)
was resolubilized in octyl glucopyranoside lysis buffer (60 mM
octyl glucopyranoside 292, 150 mM NaCl, 20 mM Tris, pH 7.5,
50 mM -glycerophosphate, 1% Triton X-100, 1% SDS) by son-
ication, followed by incubation on ice for 30 min. The deter-
gent-insoluble fractionwas centrifuged at 14,000 g for 10min
at 4 °C to remove further insoluble material. The supernatant
was kept on ice until further use.
Aliquots of detergent-soluble and detergent-insoluble frac-
tions equivalent to 106 cells were resolved on a 10% SDS-PAGE
gel with 0.35 M 2-mercaptoethanol, and transferred to nitrocel-
lulose membranes (Micron Separations, Westborough, MA).
Membranes were blocked overnight with 4% BSA in TBS at
room temperature and then washed twice with TBS-Tween.
Membraneswere probedwith the rabbit anti-chB6 as described
above (1:200 dilution in TBS-Tween) overnight at room tem-
perature. Membranes were washed with TBS-Tween and then
probed with HRP-conjugated goat anti-rabbit antisera (Pierce)
at a 1:5000 dilution for 1.5 h at room temperature. The mem-
branes were washed with TBS-Tween three times for 5 min.
Bands were visualized by chemiluminescence (Supersignal,
Pierce Chemical) and photographed with a digital imaging sys-
tem (AlphaInnotech, San Leandro, CA).
Mitochondrial Staining—Cells were incubated with HRP-
conjugated goat anti-chicken IgM as above. Cells were stained
for mitochondria using MitoTracker, diluted to 250 nM in
serum- free media (Molecular Probes), following the manufa-
cturer’s instructions. Cells were fixed, permeabilized, and incu-
batedwith FITC-conjugated donkey anti-goat IgG (1:100), pro-
cessed, and analyzed for fluorescence microscopy as above.
Proximity LigationAssays (PLA)—DT40 cells were incubated
with HRP-conjugated goat anti-chicken IgM as described
above. Cells were attached to coverslips pre-coated with 0.05%
poly-L-lysine and fixedwith 4% paraformaldehyde in PBS for 10
min at room temperature. In the controls, DT40 cellswere fixed
before incubatingwithHRP-conjugated goat anti-chicken IgM.
Cells were washed six times in immunofluorescence wash
buffer followed by immunofluorescence blocking buffer for 1 h
at room temperature. Cells were incubated with rabbit anti-
chicken raftlin (1:100) (14) or mouse BoA1 monoclonal anti-
chB6 (1:100) (24) in blocking buffer for 1 h at room tempera-
ture. Cells were processed according to the Duolink PLA
instructions, and coverslips were mounted with DAPI mount-
ing solution (Duolink) and examined using an Olympus Fluoview
1000 laser scanning confocal microscope. Quantification of PLA
images was performed using the software BlobFinder (25).
Multiplex RT-PCR for Integrin -Subunit Isoforms—Total
RNA was extracted from 5  106 DT40 cells using an RNA
extraction kit (Qiagen). RT-PCR was carried out with 1 g of
RNA, using the One-Step RT-PCR kit (Qiagen), following the
manufacturer’s instructions. The amplification primers used
were as follows: chicken integrin 3, forward, 5-TCTTCG-
GCTTCTCCGTAGC-3 (146–164), reverse, 5-ACTCAG-
CAGG TACACAGCCC-3 (824–843); chicken integrin 4,
forward, 5-ATTATAATGGGAGCCCCTGG-3 (636–665),
reverse, 5-CCCACTGAGCTCTATGTCCA-3 (1063–1082);
and chicken actin, forward, 5-AACCCCAAAGCCAACAGA-
G-3 (399–417), reverse, 5-TGAGGTAGTCCGTCAGGT-3
(619–637).
Cell Binding to Integrin Substrates—Aliquots of DT40 cells
were incubated as abovewith 20g/ml ofHRP-conjugated goat
anti-chicken IgM, 20 g/ml of nonspecific goat IgG, mouse
monoclonal FU511G2 anti-chB6 (1:100 dilution of ascites), or
nonspecific mouse IgG (1:100 dilution of ascites). Cell binding
to integrin substrates wasmonitored using the SRUBiosystems
BIND Explorer system. This biosensor measures the shift in
peak wavelength (	PWV) of light reflected from the base of a
well following cell binding after 2 h of adhesion. All experi-
ments were performed in triplicate in the presence of either 5
mMMg2 or EDTA. Cells were seeded at 2 105 cells per well
in a 96-well TiO Bind biosensor pre-coated with either 20
g/ml of laminin, 20 g/ml of gelatin, or 5% albumin, as previ-
ously described (26). Data are presented as themean S.E. and
were analyzed for statistical significance using unpaired t test
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with the Prism software package (vs5.0d, GraphPad Software,
San Diego, CA).
RESULTS
Selective Proteomic Proximity Labeling Assay Using Tyra-
mide (SPPLAT)—Bivalent antibody against IgM can be used to
induce BCR cross-linking and signal transduction (12). We
used an HRP-conjugated anti-chicken IgM for this purpose. As
the labeling reagent, we used amolecule that connects tyramide
to biotin via a spacer arm containing a disulfide bond (Fig. 1A).
The SPPLATmethodology is outlined in its general form in Fig.
1B. In the brief presence of peroxidase (i.e.HRP) and hydrogen
peroxide, tyramide moiety is converted into a free radical that
only diffuses a short distance before covalently labeling protein
residues such as tyrosines (27). After cell lysis and capture by
immobilized streptavidin, the biotinylated proteins were eluted
with reducing agent and analyzed by liquid chromatography-
mass spectrometry (LC-MS).
To initiate the tyramide biotinylation, the BCR cross-linking
was followed by a 5-min incubation with tyramide-biotin at
room temperature. Under these conditions, and consistent
with previous reports (28), the cross-linked BCR assembled
into spatially restricted membrane patches. Immunolocal-
ization confirmed that the surface distribution of the BCR
and the deposited biotin were closely correlated (Fig. 2A).
Furthermore, most of the biotin could be removed by mild
reduction with the membrane-impermeant reducing agent
TCEP (17) (Fig. 2B). Hence, the biotin predominantly
labeled the extracellular face of the plasma membrane, in
close proximity to the BCR. MS analysis confirmed the BCR
was immunoprecipitated by the anti-chicken IgM under
these conditions (supplemental Table S1).
Weused SILAC to provide a quantitative protocol (29).Here,
DT40 cells were grown in medium containing either heavy
(13C) or light (12C) L-arginine and L-lysine and these cells were
separately incubated with either specific HRP-conjugated goat
anti-chicken IgMorHRP-conjugated control antibody. Follow-
ing biotinylation, equal numbers of specifically and nonspecifi-
cally biotinylated cells were mixed, lysed, and the biotinylated
proteins from the pooled sample were isolated by streptavidin
pull-down and TCEP elution. The experiment was repeated
with reciprocal isotopic labeling. Quantitative data from 205
proteins present in both experimental replicates were analyzed
(Fig. 3A, supplemental Table S2). For each replicate, those pro-
teins with specific/nonspecific SILAC ratios that were greater
than 1 S.D. from the median of the distribution were taken as
highly significant. Twelve proteinsmatched this criterion. Nine
were intrinsic plasma membrane proteins, and three were
peripherally associated plasma membrane proteins. In six of
these cases, there was prior literature evidence for a role in BCR
signaling (Table 1).
We used immunoprecipitation to confirm the biotinylation
of the selected proteins in Table 1. We chose two proteins, for
which appropriate species cross-reacting antibodies were avail-
able. These were chB6, an intrinsic plasma membrane pro-
tein with a prominent extracellular region (16), and CDC42,
a cytosolic protein that is also peripherally associated with
the plasma membrane (30). Both chB6 and CDC42 proteins
were separately immunoprecipitated from cells that had
been specifically and nonspecifically labeled. Only the pro-
teins isolated from the specifically labeled cells were bioti-
nylated, although the degree of biotinylation was consider-
ably greater for chB6 (Fig. 3B). To retain the biotin label, we
carried out SDS-PAGE separations without reducing agent
(see “Experimental Procedures”). Under these conditions,
the anti-chB6 antibody detected bands of about 140–150
and 70–75 kDa (Fig. 3B) in the immunoprecipitates. The
FIGURE 1.Outline of the SPPLAT protocol. A, structure of the biotin-tyramide proximity labeling reagent. B, principle of the method. The antibody-directed
targeting of HRP to a surface protein of interest, followed by brief labeling with biotin-tyramide enables proteins in the immediate vicinity of the target to be
biotinylated. These are isolated by incubation of the cell lysate with streptavidin-agarose (SA), and elution with reducing agent.
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protein chB6 is known to be a disulfide-linked homodimer,
and the 140–150-kDa band has been previously identified as
the dimeric species (31). Interestingly, only the 140–150-
kDa band was biotinylated (Fig. 3B) (see “Discussion”).
Several proteins with SILAC ratios just below themedian1
S.D. level were components of the cytoskeleton, ribosomes, and
the mitochondria (Fig. 3A, supplemental Table S2). Interest-
ingly, mitochondria gathered underneath the BCR clusters in
FIGURE 2. SPPLAT analysis of the BCR-induced clusters in DT40 cells. A, co-localization of BCR and deposited biotin. Cells were preincubated with HRP-
conjugated anti-chicken IgM and tyramide biotinylated. The distribution of BCR and deposited biotin was detected using FITC-conjugated anti-goat IgG and
Alexa 568-labeled avidin as described under “Experimental Procedures.” Three representative images are shown with corresponding images rendered as
pseudo-three-dimensional. Bar 
 5 m. B, tyramide-biotinylated cells were stripped of biotin by treatment with impermeant reducing agent as described
under “Experimental Procedures.” Cells were stained with FITC-conjugated anti-goat IgG to detect BCR, and with Texas Red-conjugated avidin to detect
remaining biotin. Bar
 5 m.
FIGURE 3. Summary of quantitative SILAC data. A, scatter plot showing the isotope ratios for each protein quantitatively identified in both independent
SILAC experiments. The organelle locations of the proteins are indicated. Broken lines represent themedian value plus 1 S.D. for each data set. B, proteins chB6
and CDC42were immunoprecipitated from specifically labeled (S) and nonspecifically labeled cells (NS), then separately probedwith antibodies against chB6
or CDC42 and with HRP-streptavidin to detect biotin labeling as indicated. These samples were run under non-reducing conditions. C, immunofluorescence
image showing accumulation of mitochondria underneath the BCR surface cluster. Mitochondria were detected using MitoTracker staining, and BCR was
detected by immunofluorescence as described under “Experimental Procedures.” Bar
 5 m.
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DT40 cells (Fig. 3C). This suggests that at least some proteins in
this region of Fig. 3A may also convey biologically significant
information (see “Discussion”).
Close Association of Cross-linked BCR with Raftlin and chB6—
The cross-linked BCR enters lipid rafts (14, 32, 33). We there-
fore expect that SPPLAT should detect evidence of this
dynamic association. We detected raftlin in our data set as one
of the proteins with significant SILAC ratios (Table 1). To pro-
vide independent confirmation of this association, we per-
formed a PLA between BCR and raftlin, both before and after
BCR cross-linking. PLA is a very sensitive and stringentmethod
to detect proximity between two proteins that are typically
within 30–40 nm of each other (34). We detected a specific
PLA signal between BCR and raftlin, but only after prior BCR
cross-linking (Fig. 4). Hence, SPPLAT was able to confirm a
known aspect of BCR behavior (2).
We should also expect to detect other proteins that partition
into lipid rafts following BCR cross-linking. As noted above, the
protein chB6 consistently exhibited highly significant SILAC
ratios and was selectively biotinylated (supplemental Table S2,
Fig. 3B). This protein exhibits alloantigenic polymorphism, and
has been used extensively as a marker of avian B-lymphocytes
(35, 36), yet its functional significance is unknown. Subcellular
fractionation and immunofluorescence co-localization with
cholera B toxin confirmed that chB6 partitioned into the lipid
raft fraction of the plasma membrane (Fig. 5, A and B). We
therefore examined the co-localization of BCR and chB6 using
PLA analysis. There was a strong PLA signal following BCR
cross-linking. Moreover, the PLA signal was completely absent
in control cells whose BCRhad not been prior cross-linked (Fig.
5, C–E). This indicates there must be a significant rearrange-
ment of chB6 following BCR cross-linking such that the two
FIGURE 4. BCR cross-linking drives the close association of BCR with raftlin. A, PLA signal between raftlin and BCR in cells cross-linked with anti-BCR to
induce BCR clustering. Bar
 10 m. B, control cells fixed before anti-BCR addition showing no PLA stain in the absence of BCR clustering. Bar
 10 m. C,
quantification of data shown in A and B.
TABLE 1
Proteins with specific/nonspecific SILAC isotope ratios consistently greater than 1 S.D. above the median for both SILAC replicates
Protein name Localization Previously implicated in BCR signaling?
Evi2a Intrinsic plasma membrane No
Na,K-ATPase 3 subunit Intrinsic plasma membrane Yes (62)
Na,K-ATPase 1subunit Intrinsic plasma membrane No
Raftlin Intrinsic plasma membrane Yes (14)
Integrin 1 Intrinsic plasma membrane Yes (44)
Integrin 3 Intrinsic plasma membrane No
PTPRC (CD45) Intrinsic plasma membrane Yes (71)
CD98LC (SLC7a5) Intrinsic plasma membrane No
chB6 (Bu-1) Intrinsic plasma membrane No
Guanine nucleotide-binding protein G(i) subunit 2 (GNAI2) Peripheral plasma membrane No
CDC42 Peripheral plasma membrane Yes (30)
RhoA Peripheral plasma membrane Yes (55)
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molecules are drawn together into very close proximity within
the cluster.
Structural Insights into the chB6 Protein—The original
description of chB6 indicated an intrinsic membrane protein,
with a single transmembrane domain and a heavily glycosylated
extracellular region. However, no sequence similarity to other
proteins has previously been described (16). We re-examined
the sequence of chB6 using more sensitive homology searches
(Fig. 6). We first searched the chB6 sequence against the
SMART database (version 7) (37). This analysis identified the
endoplasmic reticulum targeting signal and a single transmem-
brane domain. Three membrane-proximal cysteines at posi-
tions 228–230 indicate a likely palmitoylation site (Fig. 6A).
This feature is commonly found in proteins that are targeted to
lipid rafts (38).
The intracellular sequence of chB6 contains conserved pro-
line residues typical of SH3-domain binding sites that are found
in signal-transducing receptors (39). Within the extracellular
region, our analysis detected the presence of two immunoglob-
ulin (Ig)-like domains (Fig. 6A). Using the iterative PSI-BLAST
program (40), we identified putative chB6 orthologs in birds
and turtles, but also more distantly related proteins. A consist-
ent feature of all these proteins was the presence of two immu-
noglobulin domains within their extracellular regions (Fig. 6, A
and B). Many of these proteins are members of the CD2 family
of immune receptors. We next analyzed the chB6 sequence
using the FUGUE sequence-structure homology recognition
server. FUGUE takes an input sequence and compares it to a
database containing known three-dimensional structures clus-
tered into related families (41). Sequence alignments are iden-
tified using environment-specific substitution tables. The sen-
sitivity of this approach relies on the fact that secondary and
tertiary structures diverge more slowly from a common ances-
tor than primary sequences (42). With chB6, FUGUE again
detected significant homologies to proteins that contain extra-
cellular Ig domains (Fig. 6A). Hence, our data consistently
places chB6 within the extended immunoglobulin superfamily
(Igsf) of cell signaling/cell-adhesion molecules.
chB6 Cross-linking Activates Cell Binding to Integrin Substrates—
Integrins are heterodimers containing one  and one  subunit
selected from18 and 8 subunits in 24 knownpairings, form-
ing a well characterized family of cell-adhesion molecules (43).
In each of our reciprocal SPPLAT experiments, we obtained
quantitative data for unique peptides corresponding to 1
and 3 integrin subunits (supplemental Table S2). We also
detected co-localization of the integrin 1 subunit with the
cross-linked BCR (Fig. 7A). Previous work has identified the
integrin 4 subunit in DT40 cells (15), but not 3. As judged by
RT-PCR, both integrin 3 and 4 subunits were expressed in
DT40 cells, but with substantially more 4 (Fig. 7B). Although
we detected 4 peptides, they did not give quantitative data in
all experiments (supplemental Table S3).
In B-lymphocytes, including DT40, the cross-linked BCR
activates integrin-dependent cell-binding (15, 44). Molecules
such asCD2 act as “integrin regulators” that co-stimulate integ-
rin-mediated cell binding during lymphocyte activation (45). In
light of our data showing that chB6 may be a distant paralog of
CD2-like molecules, we investigated integrin regulation by
chB6. A convenient way to study this phenomenon is to induce
integrin activation with appropriate cross-linking antibodies
FIGURE 5. The chicken allotypic marker chB6 partitions into lipid rafts and becomes associated with BCR following BCR cross-linking. A, lipid raft and
non-raft fractions were isolated from the DT40 plasma membrane (106 cells), separated by SDS-PAGE under reducing conditions, and blotted for chB6
expression as described under “Experimental Procedures.” B, DT40 cells were incubatedwith anti-chB6 for 20min on ice, and double stainedwith anti-mouse
FITC andAlexa 594 cholera toxin B. Cellswere visualizedby epifluorescencemicroscopy.C, PLA signal between chB6 andBCR in cells cross-linkedwith anti-BCR
to induce BCR clustering. Bar
 10 m. D, control cells fixed before anti-BCR addition showing no PLA stain in the absence of BCR clustering. Bar
 10 m. E,
quantification of data shown in C and D.
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(46). Different integrin isoforms show distinct patterns of
ligand specificity. Activated integrin 31 binds to laminin
(47), and gelatin contains exposed RGD motifs that are recog-
nized by many integrin isoforms (26). Using a real-time cell-
binding assay, we confirmed that cross-linking chB6 on DT40
initiated cell binding to both laminin and gelatin. The chB6-
induced binding was even stronger than that induced by BCR
cross-linking, and as expected for an integrin-mediated reac-
tion, it was magnesium-dependent (Fig. 7, C and D).
DISCUSSION
Enzyme-generated proximity labeling is well established in
histochemistry, where the method is used to provide localized
signal amplification (48). An early proteomic application of this
concept exploited the presence of endogenous peroxidases
combined with fluorescently labeled tyramine (49). Recently,
several groups have generalized the method to deliver the per-
oxidase onto a predetermined target. For example, coupling the
enzyme to cholera toxin B facilitated the identification of lipid
raft proteins (8). In another variation, cells have been generated
that stably express peroxidase in mitochondria, enabling the
proteomic analysis of this organelle (9). Alternatively, cells have
been generated that express biotin ligase chimeras that enable
the biotinylation of interacting partners (50).
For our assay, we chose tyramide as the labeling reagent
because the activated reagent “footprint” is typically tens to a
few hundreds of nanometers (51). Biotin was chosen because of
its strong and specific affinity for streptavidin. The introduc-
tion of a spacer arm allows efficient affinity capture, and the
disulfide bond enables high-yield specific recovery from the
affinity column following reduction. These characteristics are
well suited for the analysis of extended surface-localized pro-
tein assemblies, as exemplified by the BCR clusters.
A characteristic feature of the cross-linked BCR in B-lym-
phocytes is that proteins coalesce as large asymmetric patches
within the plasma membrane (28, 52). This makes it easier to
demonstrate the close co-localization of the BCR with depos-
ited biotin (Fig. 2A). Immunofluorescence imaging indicated
that the deposited biotin was largely restricted to the plasma
membrane, and most biotin could be removed with a mem-
brane impermeant reducing agent (Fig. 2B). Alternative aryla-
zide proximity labels can cross the plasma membrane, and
could generate high levels of nonspecific binding because they
are activated by intracellular enzymes (8).
Although there have been proteomic studies of the T cell
immune synapse (53), the molecular composition of the BCR
clusters is not so well defined. To our knowledge, a proteomic
FIGURE 6.Putative functional regions and regionsof Igdomain sequence similarity identified in chB6.A, relationship between amino acid sequence and
putative functional regions. Red sequence: ER targeting signal. Blue sequence: transmembrane domain identified using SMART. Orange underline: putative
palmitoylation site. Black underline: putative SH3-domain binding site. Purple line: region of sequence similarity to CD2 detected by PSI-BLAST.Dark green line:
regions of sequence similarity to Ig domains detected by SMART. Light green lines: regions of sequence similarity to Ig domains detectedwith FUGUE. Specific
proteins identified by FUGUE are: (i) growth arrest specific protein (Z score 16.23); (ii) junction adhesion molecule (Z score 15.31); (iii) high affinity Fc receptor
(Z score 14.55); (iv) CD43 (Z score 14.34); (v) SLAMf6 (Z score 11.76); (vi) T lymphocyte activation antigen CD80. For further details of analysis methods see
“Results.” B, schematic summary of putative functional regions in chB6.
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study on purified total lipid rafts from human B-lymphocytes is
the only such published example (54). But this work examined
all lipid raft proteins, and was not specifically intended to iden-
tify proteins in close proximity to the BCR. Our work is the first
attempt to apply the newly developed proximity labeling assays
to the assembled BCR, and thereby identify co-localized pro-
teins in this complex system.
Of the 12 highly significant proteins listed in Table 1, 9 are
intrinsic plasma membrane proteins. However, 3 of the pro-
teins are peripherally associated with the cytosolic face of the
plasma membrane. These are RhoA, CDC42, and guainine
nucleotide-binding protein G(i) subunit 2 (GNAI2). RhoA
and CDC42 are GTP-binding proteins that have been previ-
ously implicated in the regulation of BCR clustering (30, 55, 56).
In DT40, the protein Vav3 acts as a guanine nucleotide
exchange protein for this family of G proteins. Deletion of Vav3
in DT40 compromises BCR signaling, but expression of consti-
tutively active cdc42 andRhoA can re-activate downstream sig-
naling events in these cells (57).
As judged by immunofluorescence, most of the tyramide-
biotin was deposited onto the external face of the plasmamem-
brane (Fig. 2B). Nevertheless, some of the label can evidently
cross the membrane and biotinylate peripherally associated
proteins such as CDC42. However, the degree of CDC42 bioti-
nylationwas clearlymuch less than that displayed by the intrin-
sic membrane protein chB6 (Fig. 3B). It is possible that CDC42
lies at the extremity of the biotinylation footprint emanating
from the extracellularly bound HRP-conjugated anti-IgM anti-
body. It is also possible that such peripheral proteins, although
poorly biotinylated themselves, show significant SILAC ratios
because they interact with other biotinylated membrane pro-
teins within the cluster, and these interactions survive purifica-
tion on the strepatavidin column.
It should be noted that the conceptually similar proximity
labeling assay that targeted lipid raft components, mentioned
above, also detected cytosolic peripherally associated plasma-
membrane proteins (8). Indeed, one of the peripheral proteins
identified in this assay was GNAI2, which we also detected in
our significant data set (Table 1). Our results indicate a close
association of the cross-linked BCR with raftlin (Fig. 4, supple-
mental Table S2), and the cross-linked BCR is known to enter
lipid rafts (14). Hence our data provide additional support for
the view that GNAI2 is a marker for lipid rafts (8).
We emphasize that proteins detected by proximity labeling
assays need not interact with the target protein directly, but
merely lie within a limited distance from the target. We there-
fore suggest that proximity labeling assays such as SPPLATwill
be particularly appropriate for the analysis of dense but local-
ized membrane-bound protein clusters. The BCR model stud-
ied here is a good example, as are lipid rafts (8) and proteins
tightly restricted within intracellular compartments, such as
mitochondria (9).
Given the relative novelty of such proximity assays, one
aspect of this work was to gain practical insight into their appli-
cation. Our experience suggests that these assays will require
some form of proteomic quantitation if we are to effectively
separate promising candidates from proteins that bind nonspe-
cifically to the affinity matrix. In particular, quantitation was
useful to discern different degrees of likely biological signifi-
cance. For example, in our data set, there was a notable separa-
tion of distinct organelle proteins. In particular, nuclear pro-
teins were predominantly found with low SILAC ratios, mostly
FIGURE7.Cross-linking theBCRand the chB6alloantigen inDT40cells stimulates integrin-mediated cell adhesion.A, co-localizationof cross-linkedBCR
with 1 integrin. Bar
 10 m. B, RT-PCR for 3 integrin, 4 integrin, and actin. C and D, cell binding to the integrin substrates. Cells were preincubated with
goat anti-chicken IgM or non-immune goat antibody (C), or with mouse anti-chB6 or non-immune mouse antibody (D), as described under “Experimental
Procedures.” Cells were incubated with substrate-coated wells (laminin, gelatin, or albumin), and binding was assayed as the shift in peak wavelength value
(PWV) after a 2-h incubation, using the SRU Biosystems BIND Explorer system. Values are mean S.D. of 3 replicates. The p values for experiments with and
without antibody cross-linking are indicated.
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below the median (Fig. 3A). This is consistent with the nuclear
proteins being nonspecific contaminants, which is likely to be a
particularly prominent feature with DT40, given the large
nuclear to cytoplasmic ratio of these cells (10). Mitochondrial,
ribosomal, and some cytoskeletal proteins typically displayed
rather higher SILAC ratios, mostly within 1 S.D. of the median,
and distinct frommany of the nuclear proteins (Fig. 3A). Inter-
estingly, there was a clear accumulation of mitochondria
underneath the BCR clusters inDT40 cells (Fig. 3C).Mitochon-
dria are known to accrue under the immune synapses of T cells
(53). However, as far as we are aware, the concentration of
mitochondria underneath B-lymphocyte BCR clusters has not
been previously noted. The cytoskeletal regulators switch-asso-
ciated protein 70 (SWAP-70), moesin, and destrin were also
present in this region of the SILAC plot (supplemental Table
S2). They are known to accumulate underneath the cross-
linked BCR, where they play important roles in coordinating
BCR assembly (58). Ribosomes similarly concentrate under the
T cell immune synapse (53). As noted above, the biotin was
largely deposited on the surface of the cells (Fig. 2B), although a
modest degree of biotinylation could be detected for proteins
closely associated with the BCR but located on the cytoplasmic
face of the plasma membrane (Fig. 3B). Thus we suggest that
these intracellular proteins display slightly elevated SILAC
ratios not because they are strongly biotinylated themselves,
but because they are connected to biotinylated surface proteins
viamultiple low affinity, but high avidity interactionswithin the
cytoskeletal matrix (58). A summary of these interactions, with
one another and with plasma membrane proteins identified by
SPPLAT is given in Fig. 8.
The assembly of the BCR cluster is dynamic, and its compo-
sition may change during the cross-linking process. Based on
the successful identification of proteins known to be function-
ally associated with the BCR, we conclude that our time frame
was physiologically relevant. Our current protocol may, how-
ever, lead to under labeling of somemolecules. For example, the
BCR is composed of an IgM antibody together with auxiliary
subunits Ig- and Ig- (52). Antigen-induced cross-linking of
IgM leads to the dissociation of both of these subunits from the
BCR (59). We did selectively detect Ig- in our BCR immuno-
precipitation (supplemental Table S1), and we did recover Ig-
in our SILAC data set, but with too few peptides for accurate
quantitation in all samples (supplemental Table S3). It is possi-
ble that there had been partial dissociation of these subunits
prior to the tyramide-labeling step under the conditions we
used.
The BCR itself displayed a relatively low SILAC ratio (sup-
plemental Table S2). In preliminary Western blotting experi-
ments, we detected significantly more BCR in streptavidin-iso-
lated proteins from specifically labeled cells compared with
nonspecifically labeled cells (data not shown). Furthermore,
MS analysis confirmed that the BCR was immunoprecipitated
by anti-chicken IgM (supplemental Table S1). This suggests
that the relatively low SILAC ratio of the BCR may not reflect
the full extent of enrichment in the selectively biotinylated frac-
tion. The BCRs can self-assemble in lysed samples in vitro (60),
and it is possible that post-lysis mixing of heavy and light iso-
tope-labeled BCRs may be occurring in this case. Post-lysis
mixing is a known phenomenon that can artifactually reduce
SILAC ratios (61).
Among the proteins with significant SILAC ratios, a surpris-
ing findingwas the detection of1 and3 subunits of theNa,K-
ATPase. However, a monoclonal antibody specific for the 3
subunit of theNa,K-ATPase inhibitsmitogen activation of both
T- and B-lymphocytes (62). Another interesting protein iden-
tified by SPPLAT was Evi2a. Very little is known about the
FIGURE 8. Summary of the key proteins identified by SPPLAT. Proteinswith specific/nonspecific SILAC isotope ratios consistently greater than 1 S.D. above
themedian for both SILAC replicates are indicated as schematics, and labeled in blue. Additional key cytosolic proteins identified by SPPLAT and discussed in
the text are indicated in green. Black arrows indicate known interactions between proteins.
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function of this protein. Homology searches using PSI-BLAST,
SMART, and FUGUE all failed to identify any features con-
served with other proteins. In mice, several leukemogenic ret-
roviruses integrate close to the Evi2a gene in lymphocytes and
disrupt its expression (63). Hence, it is possible that Evi2a is a
lymphocyte-specific tumor suppressor. Our results provide the
first indication that Evi2a could be involved in BCR function.
The protein chB6 (Table 1, Figs. 3B and 5) is particularly
interesting. It is used extensively as an allotypic B-lymphocyte
marker in avian immunology (35, 36). Despite the fact that its
cDNAwas cloned and sequenced nearly 20 years ago (16), there
is still very little known about its structure and function. It has
been suggested that chB6 is a “death receptor,” and a phylo-
genic analysis has claimed that chB6 is related to TNFR-2 (64).
However, we do not find any statistically significant sequence
similarity at the amino acid level between chB6 and TNFR-2.
Furthermore, chB6 lacks other expected features of death
receptors such as intracellular death domains (35). In contrast,
our sequence analysis indicates that chB6 is a type I membrane
protein with a single transmembrane domain and two Ig-like
domains in the extracellular region (Fig. 6). It is related to a
large class of vertebrate Ig domain-containing immune system
proteins that include CD2-like proteins (65) and the SLAM
family of immune regulators (66). Interestingly, the gene
encoding chB6 lies within 20 kb of the CD2 gene on chicken
chromosome 1. Other genes encoding Ig domain immune reg-
ulators are also very closely linked within this chromosomal
region including CD80, a protein identified by our FUGUE
search (Fig. 6A) (ncbi.nlm.nih.gov/gene?term
 X92867).
The Western blot of immunoprecipitated chB6, analyzed by
non-reducing SDS-PAGE displayed bands at 140–150 and
70–75 kDa (Fig. 3B). The highermolecularweight bandwas not
seen under reducing SDS conditions (Fig. 5A). Hence, chB6
most likely forms a disulfide-linked homodimer in DT40 cells.
This property of chB6 has been noted previously (31). There are
eight cysteine residues within the chB6 extracellular region
(Fig. 6A). Four of these cysteines will most likely form intramo-
lecular disulfide bonds, one intramolecular disulfide bond for
each Ig domain (67). This leaves up to four cysteines that could
potentially form intermolecular disulfide bonds. Only the
higher molecular weight form of chB6 was biotinylated (Fig.
3B). This is consistent with the demonstration that the disul-
fide-bonded dimer is present on the lymphocyte plasma mem-
brane (31). The prominent non-biotinylated 70–75-kDa spe-
cies detected in the immunoprecipitations (Fig. 3B) probably
represents the immature form of the protein localized within
the intracellular secretory pathway. The dimeric structure of
chB6, together with its close association with the cross-linked
BCR could induce longer range cross-linking, and so enhance
cluster stability on the surface of the membrane.
Members of the CD2 family can regulate integrin-mediated
cell binding (46), and we observed enhanced cell binding to the
integrin substrates laminin and gelatin following cross-linking
with anti-chB6 antibodies. Indeed, this effect was slightly stron-
ger than the integrin activation induced by cross-linked BCR.
Nonspecific antibodies of the appropriate species induced sig-
nificantly less cell binding (Fig. 7, C and D).
The only integrin peptides with significant SILAC ratios and
quantified in every replicate corresponded to the 3 and 1
isoforms. Laminin is the selective ligand for integrin 31 (47)
and is a major component of the basal lamina, where it may
support neoplastic B cell extravasation (68). The protein
SLC7A5 (CD98LC) (Table 1) associates with integrin 31
(69). Similarly, CD45 (Table 1) can regulate integrin-mediated
lymphocyte cell adhesion (70). Deletion of the CD45 gene in
DT40 cells has been shown to compromise BCR signaling (71).
Interestingly, all these interactions take place in lipid rafts (2,
69, 72).
In DT40 cells, cross-linking the BCR, and cross-linking chB6
both induce apoptosis when conducted in solution (12, 31).
However, integrin binding to its substrates is known to inhibit
apoptotic signaling (44). The integrin regulation controlled by
proteins in the BCR cluster may ensure the selective survival of
correctly adhered antigen-stimulated cells. Our work thus
places chB6 into its broader evolutionary context and is the first
to link chB6 both with the BCR andwith integrin-mediated cell
binding. The chB6 protein is a good example of the sort of
molecule we hoped and expected to find using our SPPLAT
approach. In conclusion, our proximity labeling approach has
yielded novel targets for the study of B cell biology, and should
have broad applications within contemporary cell biology.
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